course and prognosis of hypertrophic cardiomyopathy in an outpatient population N Engl J Med 1989;320(12):749–755 51 Cannan CR, Reeder GS, Bailey KR, Melton LJ 3rd, Gersh BJ Natural history of hypertrophic cardiomyopathy A population-based study, 1976 through 1990 Circulation 1995;92(9):2488– 2495 52 Maron BJ, Casey SA, Poliac LC, et al Clinical course of hypertrophic cardiomyopathy in a regional United States cohort JAMA 1999;281(7):650–655 53 Maron BJ, Olivotto I, Spirito P, et al Epidemiology of hypertrophic cardiomyopathyrelated death: revisited in a large non-referralbased patient population Circulation 2000;102(8):858–864 54 Maron BJ, Rowin EJ, Casey SA, et al Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies J Am Coll Cardiol 2015;65(18):1915–1928 55 Skinner JR, Manzoor A, Hayes AM, Joffe HS, Martin RP A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants Heart 1997;77(3):229–233 56 Wilkinson JD, Lowe AM, Salbert BA, et al Outcomes in children with noonan syndrome and hypertrophic cardiomyopathy: a study from the pediatric cardiomyopathy registry Am Heart J 2012;164(3):442–448 57 Andersen PS, Havndrup O, Hougs L, et al Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives Hum Mutat 2009;30(3):363–370 58 Alfares AA, Kelly MA, McDermott G, et al Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity Genet Med 2015;17(11):880–888 59 Gruner C, Ivanov J, Care M, et al Toronto hypertrophic cardiomyopathy genotype score for prediction of a positive genotype in hypertrophic cardiomyopathy Circ Cardiovasc Genet 2013;6(1):19–26 60 Bos JM, Will ML, Gersh BJ, et al Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy Mayo Clin Proc 2014;89(6):727–737 61 Van Driest SL, Ellsworth EG, Ommen SR, et al Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy Circulation 2003;108(4):445–451 62 Liu W, Liu W, Hu D, et al Mutation spectrum in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy Am J Cardiol 2013;112(4):585–589 63 Lopes LR, Rahman MS, Elliott PM A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations Heart 2013;99(24):1800–1811 64 Hayashi T, Arimura T, Itoh-Satoh M, et al Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy J Am Coll Cardiol 2004;44(11):2192–2201 65 Bos JM, Poley RN, Ny M, et al Genotypephenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin Mol Genet Metab 2006;88(1):78–85 66 Geier C, Gehmlich K, Ehler E, et al Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy Hum Mol Genet 2008;17(18):2753–2765 67 Chiu C, Bagnall RD, Ingles J, et al Mutations in alpha-actinin-2 cause hypertrophic ...Outcomes in children with noonan syndrome and hypertrophic cardiomyopathy: a study from the pediatric cardiomyopathy registry Am Heart J 2012;164(3):442–448 57 Andersen PS, Havndrup O, Hougs L, et al